Literature DB >> 23063648

Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia.

Cinzia Tiloca1, Nicola Ticozzi, Viviana Pensato, Lucia Corrado, Roberto Del Bo, Cinzia Bertolin, Chiara Fenoglio, Stella Gagliardi, Daniela Calini, Giuseppe Lauria, Barbara Castellotti, Alessandra Bagarotti, Stefania Corti, Daniela Galimberti, Annachiara Cagnin, Carlo Gabelli, Michela Ranieri, Mauro Ceroni, Gabriele Siciliano, Letizia Mazzini, Cristina Cereda, Elio Scarpini, Gianni Sorarù, Giacomo P Comi, Sandra D'Alfonso, Cinzia Gellera, Antonia Ratti, John E Landers, Vincenzo Silani.   

Abstract

Mutations in the profilin 1 (PFN1) gene, encoding a protein regulating filamentous actin growth through its binding to monomeric G-actin, have been recently identified in familial amyotrophic lateral sclerosis (ALS). Functional studies performed on ALS-associated PFN1 mutants demonstrated aggregation propensity, alterations in growth cone, and cytoskeletal dynamics. Previous screening of PFN1 gene in sporadic ALS (SALS) cases led to the identification of the p.E117G mutation, which is likely to represent a less pathogenic variant according to both frequency data in control subjects and cases, and functional experiments. To determine the effective contribution of PFN1 mutations in SALS, we analyzed a large cohort of 1168 Italian SALS patients and also included 203 frontotemporal dementia (FTD) cases because of the great overlap between these 2 neurodegenerative diseases. We detected the p.E117G variant in 1 SALS patient and the novel synonymous change p.G15G in another patient, but none in a panel of 1512 control subjects. Our results suggest that PFN1 mutations in sporadic ALS and in FTD are rare, at least in the Italian population.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063648      PMCID: PMC3548975          DOI: 10.1016/j.neurobiolaging.2012.09.016

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  14 in total

Review 1.  Amyotrophic lateral sclerosis: an update on recent genetic insights.

Authors:  Yohei Iguchi; Masahisa Katsuno; Kensuke Ikenaka; Shinsuke Ishigaki; Gen Sobue
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

3.  Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics.

Authors:  Matthew D Figley; Gregor Bieri; Regina-Maria Kolaitis; J Paul Taylor; Aaron D Gitler
Journal:  J Neurosci       Date:  2014-06-11       Impact factor: 6.167

Review 4.  Profilin1 biology and its mutation, actin(g) in disease.

Authors:  Duah Alkam; Ezra Z Feldman; Awantika Singh; Mahmoud Kiaei
Journal:  Cell Mol Life Sci       Date:  2016-09-26       Impact factor: 9.261

5.  PFN1 mutations are also rare in the Catalan population with amyotrophic lateral sclerosis.

Authors:  Enrique Syriani; Candi Salvans; Maria Salvadó; Miguel Morales; Laura Lorenzo; Sonia Cazorla; Josep Gamez
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

6.  Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Marka van Blitterswijk; Matthew C Baker; Kevin F Bieniek; David S Knopman; Keith A Josephs; Bradley Boeve; Richard Caselli; Zbigniew K Wszolek; Ronald Petersen; Neill R Graff-Radford; Kevin B Boylan; Dennis W Dickson; Rosa Rademakers
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05-02       Impact factor: 4.092

7.  Profilin1 E117G is a moderate risk factor for amyotrophic lateral sclerosis.

Authors:  Pietro Fratta; James Charnock; Toby Collins; Anny Devoy; Robin Howard; Andrea Malaspina; Richard Orrell; Katie Sidle; Jan Clarke; Maryam Shoai; Ching-Hua Lu; John Hardy; Vincent Plagnol; Elizabeth M C Fisher
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-12-05       Impact factor: 10.154

8.  ALS-causing mutations in profilin-1 alter its conformational dynamics: A computational approach to explain propensity for aggregation.

Authors:  Mahmoud Kiaei; Meenakshisundaram Balasubramaniam; Vivek Govind Kumar; Robert J Shmookler Reis; Mahmoud Moradi; Kottayil I Varughese
Journal:  Sci Rep       Date:  2018-08-30       Impact factor: 4.379

Review 9.  The genetics of amyotrophic lateral sclerosis: current insights.

Authors:  Afnan A Alsultan; Rachel Waller; Paul R Heath; Janine Kirby
Journal:  Degener Neurol Neuromuscul Dis       Date:  2016-05-13

10.  Novel mutations support a role for Profilin 1 in the pathogenesis of ALS.

Authors:  Bradley N Smith; Caroline Vance; Emma L Scotter; Claire Troakes; Chun Hao Wong; Simon Topp; Satomi Maekawa; Andrew King; Jacqueline C Mitchell; Karan Lund; Ammar Al-Chalabi; Nicola Ticozzi; Vincenzo Silani; Peter Sapp; Robert H Brown; John E Landers; Safa Al-Sarraj; Christopher E Shaw
Journal:  Neurobiol Aging       Date:  2014-10-31       Impact factor: 5.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.